XOMA Corporation

NasdaqGM XOMA

XOMA Corporation Dividend Per Share for the Trailing 12 Months (TTM) ending September 30, 2024

XOMA Corporation Dividend Per Share is NA for the Trailing 12 Months (TTM) ending September 30, 2024. Dividend per share represents the dividends distributed per share. Indicates dividend yield potential on a per-share basis.
  • XOMA Corporation Dividend Per Share for the Trailing 12 Months (TTM) ending September 30, 2022 was USD 0.48.
Key data
Date Dividend Per Share Free Cash Flow Per Share Return on Assets (ROA) Return on Equity (ROE)
Market news
Loading...
SV Wall Street
NasdaqGM: XOMA

XOMA Corporation

CEO Mr. Owen P. Hughes Jr.
IPO Date June 6, 1986
Location United States
Headquarters 2200 Powell Street
Employees 13
Sector Healthcare
Industries
Description

XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners. It has a portfolio with approximately 70 assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.

Similar companies

ACHL

Achilles Therapeutics plc

USD 1.13

0.89%

RZLT

Rezolute, Inc.

USD 5.57

1.27%

TNGX

Tango Therapeutics, Inc.

USD 3.35

10.20%

DYN

Dyne Therapeutics, Inc.

USD 15.68

6.02%

RVMD

Revolution Medicines, Inc.

USD 44.25

4.56%

CRNX

Crinetics Pharmaceuticals, Inc.

USD 39.30

-2.72%

CELC

Celcuity Inc.

USD 12.74

1.84%

EWTX

Edgewise Therapeutics, Inc.

USD 30.03

1.80%

VINC

Vincerx Pharma, Inc.

NA

NA

CCCC

C4 Therapeutics, Inc.

USD 3.65

7.35%

STOK

Stoke Therapeutics, Inc.

USD 12.70

0.79%

ACRV

Acrivon Therapeutics, Inc. Common Stock

USD 6.97

17.94%

DSGN

Design Therapeutics, Inc.

USD 4.86

0.41%

THRD

Third Harmonic Bio, Inc.

USD 4.64

-5.31%

HOWL

Werewolf Therapeutics, Inc.

USD 1.41

0.00%

StockViz Staff

February 6, 2025

Any question? Send us an email